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This study was performed to clarify mechanisms underlying pentazocine-induced ventilatory depression
and antinociception. Spontaneous ventilation and hind leg withdrawal response against nociceptive
thermal stimulation were simultaneously recorded in anesthetized rats. Pentazocine decreased minute
volume resulting from depression of the ventilatory rate and tracheal airﬂow, and prolonged the latency
of withdrawal response. Pre-treatment of b-funaltorexamine, but not nor-binaltorphimine, signiﬁcantly
attenuated pentazocine-induced ventilatory depression, while either antagonist weakened its analgesic
potency. Comparing with effects of fentanyl and U50488, the present results suggest that ventilatory
depression induced by pentazocine is mediated by mainly m receptors and analgesia by both m and k
receptors.
© 2016 Japanese Pharmacological Society. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Pentazocine acts as an agonist of k receptors and partial agonist/
antagonist of m receptors, and has beenwidely used to treat mild to
severe pain. It has been recognized that pentazocine has an
adequate analgesic efﬁcacy with relatively weak ventilatory dis-
turbances (1,2). This may be due to the fact that opioid receptors
differently regulate analgesia and respiration (1e3). However, the
mechanisms underlying pentazocine-induced antinociception are
still controversial. Previous studies demonstrated that pentazocine
analgesia was mediated by k receptors (4) or m receptors (5,6).
Moreover, an additive (3,7) or antagonistic interaction (8,9) be-
tween m and k receptor mechanismswas also suggested. The reason
for this discrepancy is unclear but may be attributable to differ-
ences in the animal, dose, injection route and type of nociceptive
test. Similarly to the analgesic action, the mechanisms responsible
for pentazocine-induced ventilatory depression are inconsistent.
Pentazocine appears to cause ventilatory depression, but to a lesser
degree than morphine (1,3). Generally, a selective activation of k
receptors had little or a weak depressive effect on ventilation
whereas activation of m receptors exerted a strong ventilatory
depression (1,10). Furthermore, it has been reported that activation
of k receptors ameliorates m receptor-mediated respiratory
depression in rats (11) and in cats (10). For understanding the: þ81 52 757 6799.
rmacological Society.
. Production and hosting by Elsemechanisms responsible for the pentazocine action, it is important
to clarify whether its ventilatory depression and antinociception
result from an interactive action of m and k receptors or activation of
either receptor. To solve this issue, the present study investigated
effects of pentazocine on spontaneous ventilation and nociceptive
response against thermal stimulation simultaneously in anes-
thetized rats with or without selective antagonists of m and k re-
ceptors, and compared with those of selective agonists of m and k
receptors.
The present study was approved by the Animal Care Committee
at Aichi Gakuin University and performed in accordance with the
Guiding Principles for the Care and Use of Laboratory Animals
approved by The Japanese Pharmacological Society. Simultaneous
recordings of spontaneous ventilation and nociceptive response
were performed according to our previous reports (12,13). Brieﬂy,
male Wistar rats (6e7 weeks, 120e180 g) were anesthetized with
urethane (1.3 g/kg, i.p.). The tracheal airﬂowwasmeasured through
a tracheal cannula by ﬁtting to a respiratory ﬂow head (MLT1L; AD
Instruments Pty Ltd., Castle Hill, Australia) connected to a spirom-
eter (ML141; AD Instruments). Minute volume was calculated from
the tidal volume and ventilatory rate, and averaged for 10 s at each
time. Nociceptive response was assessed by a paw immersion test.
The left hind leg was connected to a force-displacement transducer
(SB-1T; Nihon Kohden, Tokyo) and the latency of withdrawal
response against noxious thermal stimulation (48.0 ± 0.2 C) was
measured every 15 min. A cut-off time was set at 10 s to avoid skin
damage. Pentazocine (an agonist of k receptors and partial agonist/vier B.V. This is an open access article under the CC BY-NC-ND license (http://
S. Kimura et al. / Journal of Pharmacological Sciences 130 (2016) 181e184182antagonist of m receptors; Sosegon injection, Maruishi Pharma-
ceutical Ltd., Osaka, Japan), fentanyl (a selective agonist of m re-
ceptors; Fentanyl injection, Daiichi Sankyo Ltd., Tokyo, Japan), U-
50488 (trans-(±)-3,4,-dichloro-N-methyl-N-[2-(1-pyrrol-idinyl)-
cyclohexyl]-benzeneacetamide hydrochloride: a selective agonist
of k receptors; TOCRIS, Ellisville, MO, USA), b-funaltorexamine (b-
FNA: an antagonist of m receptors; TOCRIS) and nor-
binaltorphimine dihydrochloride (nor-BNI: an antagonist of k re-
ceptor; TOCRIS) were diluted or dissolved in physiological saline.
Pentazocine, fentanyl and U50488 were injected intravenously af-
ter a stable control recording. To ensure the selective antagonistic
activity, b-FNA and nor-BNI were administered intraperitoneally
24 h and 48 h before the experiment, respectively. All recording
signals were digitized, monitored on computer display, and stored
on hard disk (Macintosh-PowerLab; AD Instruments). Data are
presented as the mean ± SEM. The statistical signiﬁcance was
determined by using two-tailed multiple t-test with Bonferroni
correction following one-way analysis of variance (ANOVA) at
P < 0.05.
Fig. 1A shows a typical example of spontaneous ventilation and
nociceptive reﬂex in an anesthetized rat. In control, the tracheal
airﬂow and ventilatory rate were 18.6 ± 0.3 ml/s and 115.2 ± 8.5
breaths/min (n ¼ 24), respectively. The calculated minute volume
was 78.7 ± 4.7 ml/min (n¼ 24). The latency of withdrawal response
against the nociceptive thermal stimulationwas 1.6 ± 0.2 s (n¼ 24).
Intravenous injection of pentazocine (3 and 6 mg/kg) slowed the
ventilatory rate and decreased the tracheal ﬂow, leading to
depression of the minute volume. It simultaneously prolonged theFig. 1. Effects of pentazocine on spontaneous ventilation and nociceptive response to therm
leg withdrawal movement (Movement) taken control and 15, 30 and 60 min after the penta
start of thermal stimulation (48.0 ± 0.2 C) and the onset of withdrawal movement. (B) Cha
arrows at time 0 indicate the drug injection. The difference was determined by the multiple
presented as the mean ± SEM (n ¼ number of animals). *P < 0.05 and **P < 0.01, signiﬁcalatency of withdrawal response. Summarized data are shown in
Fig. 1B. The pentazocine-induced ventilation depression and anti-
nociceptionwere dose-dependent and sustained for at least 60 min
after the injection. To clarify the receptor subtypes responsible for
the pentazocine action, antagonism by speciﬁc blockers of m and k
receptors was examined (Fig. 2). Pre-treatment of b-FNA (40mg/kg,
i.p.), a m receptor antagonist, markedly attenuated both
pentazocine-induced ventilatory depression and analgesia. Pre-
treatment of nor-BNI (10 mg/kg, i.p.), a k receptor antagonist,
weakened slightly, but signiﬁcantly, the analgesic action but had no
effect on the ventilatory depression induced by pentazocine. Fig. 3
shows effects of a selective m receptor agonist fentanyl (10 and
30 mg/kg, i.v.) or a selective k receptor agonist U50488 (1 and 3 mg/
kg, i.v.) on ventilation and nociception. Both agonists prolonged the
withdrawal latency of nociceptive reﬂex dose-dependently. Fenta-
nyl slowed the ventilatory rate and decreased the tracheal ﬂow,
resulting in a marked depression of the minute volume. U50488
temporarily increased the ventilatory rate with a small decrease in
the tracheal ﬂow, but the minute volume was unchanged. Even at
the higher dose (3 mg/kg, i.v.), which prolonged the latency of
withdrawal response to the cut-off time (10 s), U50488 had no
signiﬁcant effect on ventilation. Additionally, the effects of fentanyl
and U50488 were completely blocked by pre-treatment of b-FNA
and nor-BNI, respectively (data not shown).
In the present study, pentazocine prolonged the hind leg
withdrawal latency against the noxious thermal stimulation in
anesthetized rats. This analgesic action of pentazocine was blocked
strongly by pre-treatment of b-FNA and slightly by pre-treatment ofal stimulation in anesthetized rats. (A) Typical traces of tracheal airﬂow (TA) and hind
zocine (3 mg/kg, i.v.) injection. Double-ended arrows indicate the time lag between the
nges of latencies of withdrawal movement (Latency) and minute volume (VE). Upward
t-test with the Bonferroni correction following analysis of variance (ANOVA). Data are
ntly different from the corresponding value in the saline group.
Fig. 2. Antagonism by b-FNA and nor-BNI against pentazocine-induced ventilatory depression and analgesia in anesthetized rats. (A) Typical traces of tracheal airﬂow (TA) and hind
leg withdrawal movement (Movement) taken control and 15, 30 and 60 min after the pentazocine (3 mg/kg, i.v.) injection. b-FNA (40 mg/kg, i.p.) was pretreated 24 h before the
experiment and nor-BNI (10 mg/kg, i.p.) was pretreated 48 h before the experiment. Double-ended arrows indicate the time lag between the start of thermal stimulation
(48.0 ± 0.2 C) and the onset of withdrawal movement. (B) Changes of latencies of withdrawal movement (Latency) and minute volume (VE). Upward arrows at time 0 indicate the
pentazocine injection. The difference was determined by the multiple t-test with the Bonferroni correction following analysis of variance (ANOVA). Data are presented as the
mean ± SEM (n ¼ number of animals). *P < 0.05 and **P < 0.01, signiﬁcantly different from the corresponding value in the pentazocine group.
Fig. 3. Effects of fentanyl andU50488onspontaneousventilationandnociceptive response to thermal stimulation inanesthetizedrats. (A) Typical tracesof tracheal airﬂow(TA)andhind leg
withdrawal movement (Movement) taken control and 5, 20 and 35 min after the fentanyl (10 mg/kg, i.v.) injection, or 15, 30 and 60 min after the U50488 (1 mg/kg, i.v.) injection. Double-
ended arrows indicate the time lag between the start of thermal stimulation (48.0 ± 0.2 C) and the onset of withdrawal movement. (B) Changes of latencies of withdrawal movement
(Latency) and minute volume (VE). Upward arrows at time 0 indicate the drug injection. The difference was determined by the multiple t-test with the Bonferroni correction following
analysisof variance (ANOVA).Data arepresentedas themean±SEM(n¼numberofanimals). *P<0.05 and **P<0.01, signiﬁcantlydifferent fromthe corresponding value in thesalinegroup.
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by U50488 exerted a signiﬁcant antinociceptive effect. Therefore, it
is thought that both m and k receptors can be implicated additively
in pentazocine-induced antinociception and the former may play a
pivotal role. This is consistent with the previous result reported by
Bidlack et al. (3). Furthermore, it has been shown in m receptor
knockout mice that m receptors are involved principally in
pentazocine-induced thermal antinociception (6). Shu and co-
workers (9) demonstrated that the antinociceptive effects of
pentazocine exhibited biphasic bell-shape dose-response curves;
low dose (3e30 mg/kg, s.c.)-effects were mediated by m receptors,
and high dose (56e100 mg/kg, s.c.)-effects were mediated by m
receptors and compromised by k receptors. Since doses of
pentazocine in the present study were low and since the analgesic
potency of pentazocine was not increased under blockade of k re-
ceptors by nor-BNI (Fig. 2), it is unlikely that an antagonistic
interaction between m and k receptors occurred.
Pentazocine decreased the minute volume resulting from
depression of the ventilatory rate and tidal volume in anesthetized
rats. This ventilatory depression was markedly attenuated under b-
FNA treatment, but unchanged under nor-BNI treatment. Further-
more, fentanyl, but not U50488, depressed spontaneous ventilation
at doses that exhibited an antinociceptive action. These results
suggest that m receptors activated by pentazocine contribute
mainly to ventilatory depression but k receptors do not. This is
supported by our unpublished observation using whole-body
plethysmography that hypercapnic ventilatory response was
signiﬁcantly inhibited by pentazocine (30 mg/kg, i.p.) and fentanyl
(0.1 mg/kg, i.p.) but not by U50488 (10 mg/kg, i.p.) in unrestrained
and unanesthetized rats (Kimura et al., unpublished data). There-
fore, the present result that m receptors mediated the pentazocine-
induced ventilatory depression may explain the evidence that
pentazocine possesses a relatively low depressant potency on
respiration as a partial agonist at m receptors (1e3).
In conclusion, the present study performed simultaneous re-
cordings of spontaneous ventilation and nociceptive thermal
response in anesthetized rats and was able to distinguish clearly
the underlying mechanisms between pentazocine-induced venti-
latory depression and analgesia; the former was mediated mainly
by m receptors and the latter by both m and k receptors. The dis-
tribution of opioid receptors in the central pain control areas
including the periaqueductal gray and raphe nucleus indicates
substantial overlap between m and k receptors (14). These two re-
ceptors are also distributedwidely in the respiratory-related area in
the brainstem (15). Since pentazocine is shown to bind with highafﬁnity to both m and k receptors (4,6), the distinct involvement of
these receptors in ventilation and analgesia may at least partly
reﬂect the pentazocine action. The present results support clinical
use of pentazocine for pain management with little or no effect on
ventilation.Conﬂicts of interest
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